<DOC>
	<DOCNO>NCT02582801</DOCNO>
	<brief_summary>18F-Alfatide Ⅱ PET/CT breast cancer patient</brief_summary>
	<brief_title>Clinical Research 18F-Alfatide Ⅱ PET/CT Breast Cancer</brief_title>
	<detailed_description>The investigator aim assess clinical application 18F-Alfatide Ⅱ PET/CT diagnosis treatment response monitoring breast cancer .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>The patient suspect diagnosed breast cancer receive treatment ; It must fulfill ethical requirement subject sign informed consent . Pregnancy nurse mother ; Those patient accompany serious disease cardiac functional insufficiency , hepatic renal function insufficiency .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>PET/CT</keyword>
	<keyword>Alfatide Ⅱ</keyword>
	<keyword>breast cancer</keyword>
</DOC>